Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

NCT01516840 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Deep Vein Thrombosis

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Unfractionated heparin
DRUG: Warfarin

Sponsor

Bayer

Collaborators

[object Object]